Trevi Therapeutics, Inc. (TRVI)
11.14
+0.08
(+0.77%)
USD |
NASDAQ |
Feb 12, 11:04
Trevi Therapeutics Shareholders Equity (Quarterly) : 189.79M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CorMedix, Inc. | 374.13M |
| Arbutus Biopharma Corp. | 77.40M |
| Bristol Myers Squibb Co. | -- |
| ACADIA Pharmaceuticals, Inc. | 917.27M |
| Alnylam Pharmaceuticals, Inc. | 233.89M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 199.36M |
| Total Liabilities (Quarterly) | 9.568M |
| Debt to Equity Ratio | 0.0043 |
| Current Ratio | 21.93 |
| Net Debt Paydown Yield | 0.01% |